News archive

The Ulla and Ingemar Dahlberg Foundation has decided to donate SEK 50 million to Karolinska Institutet. The grant will be used for a new professorship in vision science with a focus on ocular neurobiology and have the full name "Ulla och Ingemar Dahlbergs professur i synvetenskap med inriktning mot okulär neurobiologi" (Ulla and Ingemar Dahlberg's Professorship in Visual Science with specialization in Ocular Neurobiology).

KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Erling-Persson Foundation for a clinical phase 1 trial on macular degeneration, a common age-related eye disease. By transplanting retinal cells from embryonic stem cells, the researchers hope to curb any further loss of vision and ultimately recover lost sight.

This year's KLOK award goes to the Optometry program, which together with the St. Erik Eye Hospital has developed a clinical training clinic where students from several educational programs can broaden and deepen their knowledge in an interprofessional learning environment.

Blind people are better at sensing their own heartbeats than sighted, shows a study by researchers at Karolinska Institutet in Sweden and Jagiellonian University in Poland. The study indicates that blindness leads to a heightened ability in feeling signals from the inner body. The findings are published in the Journal of Experimental Psychology: General.

Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on animal and cell models for glaucoma. The study, published in Redox Biology, may be a future neuroprotective therapy in glaucoma in humans. A clinical trial will start in the autumn.

In the search for new ways to treat the incurable eye disease glaucoma, researchers at Karolinska Institutet and St. Erik Eye Hospital have discovered more clues as to its pathogenesis. A new study shows how metabolic disturbance of the neurons coincide with raised pressure in the eye. In animal and cell models, rapamycin and pyruvate treatments were shown to have a protective effect. The study is published in the journal PNAS.

Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk A/S will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generated from embryonic stem cells will be transplanted into patients. The aim is to develop a completely new cell therapy for this common but currently incurable eye disease.

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly. Using the CRISPR/Cas9 gene editing, they have also managed to modify the cells so that they can hide from the immune system to prevent rejection. The studies are published in the scientific journals Nature Communications and Stem Cell Reports.